| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.009 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |